$ORGN
Origin Materials, Inc.

2021 Q1 Form 10-Q Financial Statement

#000119312521164213 Filed on May 18, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $2.880M $9.070K
YoY Change
Gross Profit -$2.880M -$9.070K
YoY Change
Gross Profit Margin
Selling, General & Admin $3.948M $4.520M
YoY Change
% of Gross Profit
Research & Development $1.309M $830.0K
YoY Change
% of Gross Profit
Depreciation & Amortization $115.0K $170.0K
YoY Change
% of Gross Profit
Operating Expenses $5.372M $0.00 $0.00
YoY Change
Operating Profit -$911.8K -$2.880M -$9.069K
YoY Change 9953.9%
Interest Expense $280.0K -$22.92M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$48.20M -$16.80M
YoY Change
Pretax Income -$53.57M -$25.80M -$9.070K
YoY Change 590539.47%
Income Tax
% Of Pretax Income
Net Earnings -$53.57M -$25.80M -$9.069K
YoY Change 590604.6%
Net Earnings / Revenue
Basic Earnings Per Share -$0.86
Diluted Earnings Per Share -$0.86 -$284.9K -$134.20
COMMON SHARES
Basic Shares Outstanding 62.65M shares
Diluted Shares Outstanding 62.65M shares

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $359.1K $1.309M
YoY Change
Cash & Equivalents $359.1K $1.309M $0.00
Short-Term Investments $0.00
Other Short-Term Assets $241.8K $220.9K
YoY Change
Inventory
Prepaid Expenses $241.8K $220.9K
Receivables
Other Receivables $48.00K
Total Short-Term Assets $600.9K $2.005M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $45.10M
YoY Change
Goodwill
YoY Change
Intangibles $258.0K
YoY Change
Long-Term Investments $724.8M $724.7M
YoY Change
Other Assets $62.00K
YoY Change
Total Long-Term Assets $724.8M $45.42M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $600.9K $2.005M
Total Long-Term Assets $724.8M $45.42M
Total Assets $725.4M $47.43M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.700M
YoY Change
Accrued Expenses $593.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $168.6K $7.764M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $86.38M $2.500M
YoY Change
Total Long-Term Liabilities $86.38M $2.500M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $168.6K $7.764M
Total Long-Term Liabilities $86.38M $2.500M
Total Liabilities $86.55M $47.31M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$9.692M -$98.89M
YoY Change
Common Stock $6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$52.30M $122.0K $15.93K
YoY Change
Total Liabilities & Shareholders Equity $725.4M $47.43M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income -$53.57M -$25.80M -$9.069K
YoY Change 590604.6%
Depreciation, Depletion And Amortization $115.0K $170.0K
YoY Change
Cash From Operating Activities -$3.360M -$138.3K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $741.0K $650.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$793.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $55.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $11.82M 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$3.360M -138.3K 0.000
Cash From Investing Activities -$793.0K 0.000
Cash From Financing Activities $11.82M 0.000 0.000
Net Change In Cash $7.563M -138.3K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$3.360M -$138.3K $0.00
Capital Expenditures $741.0K $650.0K
Free Cash Flow -$4.101M -$788.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 aacqu Percentage Of Public Shares Redeemable On Failure To Acquire Business Within Specified Time
PercentageOfPublicSharesRedeemableOnFailureToAcquireBusinessWithinSpecifiedTime
1.00
CY2020Q3 aacqu Percentage Of Holders Entitled To Make Demands
PercentageOfHoldersEntitledToMakeDemands
0.20
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 aacqu Federal Depository Insurance Coverage Limit
FederalDepositoryInsuranceCoverageLimit
250000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1123407
CY2021Q1 aacqu Percentage Of Common Stock Outstanding On Common Stock Conversion From One Class To Another
PercentageOfCommonStockOutstandingOnCommonStockConversionFromOneClassToAnother
0.20
CY2021Q1 us-gaap Cash
Cash
359067
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
241813
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
359067
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 aacqu Formation And Operating Costs
FormationAndOperatingCosts
911788
CY2021Q1 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
1500000
CY2021Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.50
CY2021Q1 us-gaap Assets Current
AssetsCurrent
600880
CY2021Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
724779404
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14689698
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9692410
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000008
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
725380284
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2021Q1 aacqu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
25357500
CY2021Q1 us-gaap Liabilities
Liabilities
86545982
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-911788
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
62928
CY2021Q1 aacqu Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
-17028800
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15931
CY2021Q1 aacqu Marketable Securities Held To Maturity Securities
MarketableSecuritiesHeldToMaturitySecurities
-62928
CY2021Q1 aacqu Change In Fair Value Of Warrants Liability
ChangeInFairValueOfWarrantsLiability
-17028800
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20946
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-764340
CY2021Q1 us-gaap Assets
Assets
725380284
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
16179940
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
168394
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-764340
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 aacqu Change In Value Of Common Stock Redemption
ChangeInValueOfCommonStockRedemption
-16179938
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
724500000
CY2020Q3 aacqu Stock Issuance Costs
StockIssuanceCosts
40686819
CY2020Q3 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
14490000
CY2020Q3 aacqu Deferred Underwriting Fees
DeferredUnderwritingFees
25357500
CY2020Q3 aacqu Other Offering Costs
OtherOfferingCosts
839319
CY2020Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
724500000
CY2020Q3 aacqu Warrants Issued Price Per Warrant
WarrantsIssuedPricePerWarrant
10.00
CY2020Q3 aacqu Percentage Of Fair Market Value Of Target Business To Net Assets Held In The Trust Account
PercentageOfFairMarketValueOfTargetBusinessToNetAssetsHeldInTheTrustAccount
0.80
CY2020Q3 aacqu Threshold Percentage On Redemption Of Public Shares Without Written Consent
ThresholdPercentageOnRedemptionOfPublicSharesWithoutWrittenConsent
0.15
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Artius Acquisition Inc.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001802457
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
76500
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25872350
CY2021Q1 aacqu Underwriting Fee Per Unit
UnderwritingFeePerUnit
0.35
CY2021Q1 aacqu Deferred Underwriting Fees
DeferredUnderwritingFees
25357500
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
78048668
CY2020Q1 aacqu Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfShares
25000
CY2021Q1 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
450000
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 aacqu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
25357500
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2020Q4 us-gaap Liabilities
Liabilities
103406388
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
726060750
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30869475
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
168614
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
220
CY2020Q1 aacqu Formation And Operating Costs
FormationAndOperatingCosts
9069
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9069
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-16179938
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9069
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9069
CY2020Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
76500
CY2021Q1 dei Security12b Title
Security12bTitle
Class A ordinary shares, par value $0.0001 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
AACQ
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020Q4 us-gaap Cash
Cash
1123407
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
220867
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1344274
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
724716476
CY2020Q4 us-gaap Assets
Assets
726060750
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
168614
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
220
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
61019868
CY2020Q1 aacqu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
381329
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-01-24
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Share Price
SharePrice
9.20
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0

Files In Submission

Name View Source Status
0001193125-21-164213-index-headers.html Edgar Link pending
0001193125-21-164213-index.html Edgar Link pending
0001193125-21-164213.txt Edgar Link pending
0001193125-21-164213-xbrl.zip Edgar Link pending
aacqu-20210331.xml Edgar Link completed
aacqu-20210331.xsd Edgar Link pending
aacqu-20210331_cal.xml Edgar Link unprocessable
aacqu-20210331_def.xml Edgar Link unprocessable
aacqu-20210331_lab.xml Edgar Link unprocessable
aacqu-20210331_pre.xml Edgar Link unprocessable
d326356d10q.htm Edgar Link pending
d326356dex311.htm Edgar Link pending
d326356dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending